Overview

Exenatide for Treating Cocaine Use Disorder

Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect information about whether exenatide (Bydureon) may be safe and helpful as a medication treatment for individuals who want to stop using cocaine. Although exenatide (Bydureon) is approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes, it has not been approved by the FDA to treat cocaine use; therefore, it is called an investigational drug.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Treatments:
Exenatide